Rocket Pharmaceuticals, Inc.
RCKT· Nasdaq
Released Aug 6, 2015, after the close
10-Q filed Aug 7, 2015, 38 days after period end · 0001193125-15-281532
| Metric | Q2 2015 | Q2 2014 |
|---|---|---|
| Net Income | -$2.39M | -$2.85M |
| EPS Diluted | -$0.15 | -$3.81 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 7, 2015 · 38 d after period end